As extensively reviewed elsewhere [15], proteasome inhibition results in multiple deleterious downstream effects in cancer cells, including downregulation of NF-κB signaling, alteration of cytokine secretion, stabilization of p53, and cell cycle arrest. Here, NFKB1 is linked to cancer.